Suddenly, a New Model for Device Acquisitions
This article was originally published in Start Up
Executive Summary
The medical device industry has, for a long time, separated naturally into big players and small. But recent consolidation, particularly in areas such as cardiovascular and orthopedic devices, has created an exaggerated dichotomy, with billion-dollar giants on one end, tiny start-ups on the other, and virtually no one in the middle. Now, a small group of investors--among them, Warburg Pincus and Galen Partners-- is trying to find value in what has traditionally been a device company's no man's land, by putting together small and mid-sized companies.
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.